Funding Raised: Over $130 million in funding through non-dilutive license fees, milestone payments, and equity financing since the start of 2025. Clinical Progress: Rolling submission of a Biologics ...
CEO Alexander Macrae stated that "Sangamo continued to make significant pipeline progress in 2025 and into the first quarter of '26. Set against a backdrop of regulatory and market uncertainty and ...
Good afternoon, and welcome to the Sangamo Therapeutics Fourth Quarter and Full Year 2025 Teleconference Call. Please be advised that today's conference is being recorded. I would now like to turn the ...
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...
Our CVIS (Cardiovascular Information Management System) is a unique software solution that empowers you to improve the clinical and financial performance of your cardiology department. Clinical ...
Announced in June, positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across ...
mu1 = make_prior ( # Mu is linear because we want to allow the mean to vary as a function of the covariates. linear=True, # The slope coefficients are assumed to be normally distributed, with a mean ...
#' @param id (`character`)\cr unique identifier of patients in datasets, default to `"USUBJID"`. #' @param grade (`character`)\cr name of the severity level variable. #' @param label_grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results